OKLAHOMA CITY, Okla.--(BUSINESS WIRE)--Cytovance® Biologics LLC, a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from mammalian cell culture, today announced that it has added Michael Faughnan to its sales and business development team to meet growing demand for the company’s unique services portfolio. Faughnan is responsible for leading sales and business development efforts in western North America, including introducing key prospects to Cytovance’s comprehensive range of process development and cGMP manufacturing services, as well as the company’s portfolio of technical and strategic support services.
